A new study compared the use of anti-CGRP monoclonal antibodies versus propranolol for migraine prevention in early pregnancy and risk of spontaneous abortion.
New research found that post-menopausal women had a higher risk of retinopathy, cardiovascular disease, neuropathy, falls, and moderate-to-severe depressive symptoms.
Product monographs are being updated to include the risk of serious hypertension, myocardial infarction (MI), stroke and seizures in postpartum women taking cabergoline.
